Home LiteratureArticle Details
PMID: 24163099 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing.

Nucleic acids research ·Vol. 42 ·No. 2 ·2014-01-00 ·Pages 926-40

Frum RA, Singh S, Vaughan C, Mukhopadhyay ND, Grossman SR, Windle B, Deb S, Deb SP

Abstract

Conventional paradigm ascribes the cell proliferative function of the human oncoprotein mouse double minute2 (MDM2) primarily to its ability to degrade p53. Here we report that in the absence of p53, MDM2 induces replication stress eliciting an early S-phase checkpoint response to inhibit further firing of DNA replication origins. Partially synchronized lung cells cultured from p53-/-:MDM2 transgenic mice enter S phase and induce S-phase checkpoint response earlier than lung cells from p53-/- mice and inhibit firing of DNA replication origins. MDM2 activates chk1 phosphorylation, elevates mixed lineage lymphoma histone methyl transferase levels and promotes checkpoint-dependent tri-methylation of histone H3 at lysine 4, known to prevent firing of late replication origins at the early S phase. In the absence of p53, a condition that disables inhibition of cyclin A expression by MDM2, MDM2 increases expression of cyclin D2 and A and hastens S-phase entry of cells. Consistently, inhibition of cyclin-dependent kinases, known to activate DNA replication origins during firing, inhibits MDM2-mediated induction of chk1 phosphorylation indicating the requirement of this activity in MDM2-mediated chk1 phosphorylation. Our data reveal a novel pathway, defended by the intra-S-phase checkpoint, by which MDM2 induces unscheduled origin firing and accelerates S-phase entry of cells in the absence of p53.

MeSH Terms
Animals Caffeine/pharmacology Cell Line Checkpoint Kinase 1 Cyclin A/metabolism Cyclin D2/metabolism DNA Replication Genes, p53 Histone-Lysine N-Methyltransferase/metabolism Histones/metabolism Humans Mice Mice, Knockout Mice, Transgenic Protein Kinase Inhibitors/pharmacology Protein Kinases/metabolism Proto-Oncogene Proteins c-mdm2/genetics,metabolism Replication Origin/drug effects S Phase Cell Cycle Checkpoints/genetics Stress, Physiological/genetics
Chemicals
Cyclin A Cyclin D2 Histones Protein Kinase Inhibitors Caffeine Histone-Lysine N-Methyltransferase MDM2 protein, human Proto-Oncogene Proteins c-mdm2 Protein Kinases CHEK1 protein, human Checkpoint Kinase 1 Chek1 protein, mouse
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Frum Rebecca A
Division of Hematology, Oncology and Palliative Care, Department of Medicine, The Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA, Department of Biochemistry and Molecular Biology, The Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA, Department of Biostatistics, The Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA and Department of Medicinal Chemistry, The Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Singh Shilpa
Vaughan Catherine
Mukhopadhyay Nitai D
Grossman Steven R
Windle Brad
Deb Sumitra
Deb Swati Palit
References (53)
53 references, click to expand
  1. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.
    Nat Chem Biol. 2008 Jun;4(6):357-65 PMID: 18469809
  2. The S-phase checkpoint: targeting the replication fork.
    Biol Cell. 2009 Aug 19;101(11):617-27 PMID: 19686094
  3. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress.
    Oncogene. 2013 Aug 8;32(32):3744-53 PMID: 22945645
  4. MDM2 is a central node in the p53 pathway: 12 years and counting.
    Curr Cancer Drug Targets. 2005 Feb;5(1):3-8 PMID: 15720184
  5. The growth arrest function of the human oncoprotein mouse double minute-2 is disabled by downstream mutation in cancer cells.
    Cancer Res. 2005 Mar 1;65(5):1839-48 PMID: 15753382
  6. Breaking news: high-speed race ends in arrest--how oncogenes induce senescence.
    Trends Cell Biol. 2007 Nov;17(11):529-36 PMID: 17980599
  7. Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
    Br J Cancer. 1998;77(3):374-84 PMID: 9472631
  8. The DNA damage response during an unperturbed S-phase.
    DNA Repair (Amst). 2007 Jul 1;6(7):914-22 PMID: 17374515
  9. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication.
    Nucleic Acids Res. 2012 Jan;40(2):477-86 PMID: 21937510
  10. MDM2 controls the timely expression of cyclin A to regulate the cell cycle.
    Mol Cancer Res. 2009 Aug;7(8):1253-67 PMID: 19671680
  11. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.
    Genes Dev. 2010 Aug 1;24(15):1580-9 PMID: 20679392
  12. N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation.
    Oncogene. 1995 Apr 6;10(7):1275-82 PMID: 7731677
  13. Use of the DNA fiber spreading technique to detect the effects of mutant p53 on DNA replication.
    Methods Mol Biol. 2013;962:147-55 PMID: 23150444
  14. An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation.
    J Exp Med. 2012 Mar 12;209(3):455-61 PMID: 22370720
  15. Cell cycle regulatory functions of the human oncoprotein MDM2.
    Mol Cancer Res. 2003 Dec;1(14):1009-16 PMID: 14707284
  16. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
    Nature. 2006 Nov 30;444(7119):638-42 PMID: 17136094
  17. Right place, right time, and only once: replication initiation in metazoans.
    Cell. 2005 Oct 7;123(1):13-24 PMID: 16213209
  18. Chk1-cyclin A/Cdk1 axis regulates origin firing programs in mammals.
    Chromosome Res. 2010 Jan;18(1):103-13 PMID: 20013152
  19. Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions.
    Genes Dev. 2007 Oct 1;21(19):2385-98 PMID: 17908926
  20. MLL targets SET domain methyltransferase activity to Hox gene promoters.
    Mol Cell. 2002 Nov;10(5):1107-17 PMID: 12453418
  21. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes.
    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4960-4 PMID: 8197165
  22. The multiple facets of the intra-S checkpoint.
    Cell Cycle. 2008 Aug;7(15):2315-20 PMID: 18677104
  23. Maintaining genome stability at the replication fork.
    Nat Rev Mol Cell Biol. 2010 Mar;11(3):208-19 PMID: 20177396
  24. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis.
    EMBO J. 1998 May 1;17(9):2513-25 PMID: 9564034
  25. Function and dysfunction of the human oncoprotein MDM2.
    Front Biosci. 2002 Jan 01;7:d235-43 PMID: 11779693
  26. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
    Mol Cell Biol. 1993 Jan;13(1):301-6 PMID: 8417333
  27. Human Oncoprotein MDM2 Up-regulates Expression of NF-κB2 Precursor p100 Conferring a Survival Advantage to Lung Cells.
    Genes Cancer. 2011 Oct;2(10):943-55 PMID: 22701761
  28. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
    Proc Natl Acad Sci U S A. 1990 Jan;87(1):6-10 PMID: 1688660
  29. MDM2 and prognosis.
    Mol Cancer Res. 2004 Jan;2(1):1-8 PMID: 14757840
  30. Gli1 mediates lung cancer cell proliferation and Sonic Hedgehog-dependent mesenchymal cell activation.
    PLoS One. 2013 May 07;8(5):e63226 PMID: 23667589
  31. Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint.
    Nature. 2010 Sep 16;467(7313):343-6 PMID: 20818375
  32. Regulation of DNA replication by the S-phase DNA damage checkpoint.
    Cell Div. 2009 Jul 03;4:13 PMID: 19575778
  33. Characterization of a novel ATR-dependent, Chk1-independent, intra-S-phase checkpoint that suppresses initiation of replication in Xenopus.
    J Cell Sci. 2004 Dec 1;117(Pt 25):6019-30 PMID: 15536124
  34. DNA replication in early S phase pauses near newly activated origins.
    Cell Cycle. 2008 May 15;7(10):1440-8 PMID: 18418075
  35. The p53-Mdm2 module and the ubiquitin system.
    Semin Cancer Biol. 2003 Feb;13(1):49-58 PMID: 12507556
  36. Senescence in tumours: evidence from mice and humans.
    Nat Rev Cancer. 2010 Jan;10(1):51-7 PMID: 20029423
  37. Rearrangement of the p53 gene in human osteogenic sarcomas.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9 PMID: 2823272
  38. The human MDM-2 oncogene is overexpressed in leukemias.
    Blood. 1993 Nov 1;82(9):2617-23 PMID: 8219216
  39. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.
    Cell Death Differ. 2013 Apr;20(4):558-66 PMID: 23238568
  40. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes.
    Cell Cycle. 2005 Mar;4(3):388-91 PMID: 15738651
  41. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
    Cell Cycle. 2008 Jul 15;7(14):2215-24 PMID: 18635970
  42. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
    Cancer Res. 1999 Sep 1;59(17):4375-82 PMID: 10485486
  43. MDM2, an introduction.
    Mol Cancer Res. 2003 Dec;1(14):993-1000 PMID: 14707282
  44. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15608-12 PMID: 9861017
  45. DNA replication in eukaryotic cells.
    Annu Rev Biochem. 2002;71:333-74 PMID: 12045100
  46. PTEN, a general negative regulator of cyclin D expression.
    Cell Res. 2007 Apr;17(4):291-2 PMID: 17426697
  47. Mechanisms of replication fork protection: a safeguard for genome stability.
    Crit Rev Biochem Mol Biol. 2012 May-Jun;47(3):222-35 PMID: 22324461
  48. Oncogene-induced senescence pathways weave an intricate tapestry.
    Cell. 2007 Jan 26;128(2):233-4 PMID: 17254959
  49. Senescence of human fibroblasts induced by oncogenic Raf.
    Genes Dev. 1998 Oct 1;12(19):2997-3007 PMID: 9765202
  50. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
    Mol Cell Biol. 1993 Nov;13(11):6849-57 PMID: 8413278
  51. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.
    EMBO J. 1991 Jun;10(6):1565-9 PMID: 2026149
  52. In focus: MLL-rearranged leukemia.
    Leukemia. 2013 Jun;27(6):1224-8 PMID: 23515098
  53. Facilitating replication under stress: an oncogenic function of MYC?
    Nat Rev Cancer. 2009 Jun;9(6):441-4 PMID: 19461668
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2014-01-00
Epub
2013-00-24
Pages
926-40
Language
English
Region
England
NLM ID
0411011
PMCID
PMC3902934
Subset
IM
Grants
NCI NIH HHS · CA 121144 · United States
NCI NIH HHS · CA107532 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com